New Strong Buy Stocks for June 4th

By Zacks Equity Research | June 04, 2025, 5:52 AM

Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today:

BioCryst Pharmaceuticals BCRX: This company which is a leader in the use of crystallography and structure-based drug design for the development of novel therapeutics to treat cancer, cardiovascular diseases, autoimmune diseases, and viral infections, has seen the Zacks Consensus Estimate for its next year earnings increasing 83.3% over the last 60 days.

BioCryst Pharmaceuticals, Inc. Price and Consensus

BioCryst Pharmaceuticals, Inc. Price and Consensus

BioCryst Pharmaceuticals, Inc. price-consensus-chart | BioCryst Pharmaceuticals, Inc. Quote

OptimizeRx OPRX: This company which provides consumer and physician platforms to help patients better afford and comply with their medicines and healthcare products, has seen the Zacks Consensus Estimate for its current year earnings increasing 27.5% over the last 60 days.

OptimizeRx Corp. Price and Consensus

OptimizeRx Corp. Price and Consensus

OptimizeRx Corp. price-consensus-chart | OptimizeRx Corp. Quote

Bridgewater Bancshares BWB: This company which provides personal and commercial banking products and services to commercial real estate investors, small business entrepreneurs and high-net-worth individuals, has seen the Zacks Consensus Estimate for its current year earnings increasing 11.7% over the last 60 days.

Bridgewater Bancshares, Inc. Price and Consensus

Bridgewater Bancshares, Inc. Price and Consensus

Bridgewater Bancshares, Inc. price-consensus-chart | Bridgewater Bancshares, Inc. Quote

Palomar Holdings PLMR: This rapidly growing and profitable company focused on the provision of catastrophe insurance for personal and commercial property, has seen the Zacks Consensus Estimate for its current year earnings increasing 4.6% over the last 60 days.

Palomar Holdings, Inc. Price and Consensus

Palomar Holdings, Inc. Price and Consensus

Palomar Holdings, Inc. price-consensus-chart | Palomar Holdings, Inc. Quote

Ferrari RACE: This company which is engaged in designing, manufacturing and selling sports cars, has seen the Zacks Consensus Estimate for its current year earnings increasing 4.4% over the last 60 day.

Ferrari N.V. Price and Consensus

Ferrari N.V. Price and Consensus

Ferrari N.V. price-consensus-chart | Ferrari N.V. Quote

 

You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report


 
BioCryst Pharmaceuticals, Inc. (BCRX): Free Stock Analysis Report
 
OptimizeRx Corp. (OPRX): Free Stock Analysis Report
 
Ferrari N.V. (RACE): Free Stock Analysis Report
 
Bridgewater Bancshares, Inc. (BWB): Free Stock Analysis Report
 
Palomar Holdings, Inc. (PLMR): Free Stock Analysis Report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research

Latest News